| Literature DB >> 34511718 |
Kamlesh Kumari1, Ajay Kumar2, Indra Bahadur3, Prashant Singh4.
Abstract
Hormones like testosterone and progesterone in the humans play significant role in the regulation of various biological processes like the body growth, reproduction, and others. In last two decades, researchers are using ionic liquids (ILs) extensively in different areas of sciences, and they are a novel class of compounds as well as their polarity can be tuned. ILs are multidisciplinary in nature and can be used in chemistry, materials science, chemical engineering, and environmental science. Further, ILs are being explored to increase the solubility of drugs or biological potential molecules. Testosterone and progesterone are found to be not very polar in nature; therefore, the authors attempt to increase the solubility of testosterone and progesterone via interaction with ILs. It was studied with density functional theory calculations using Gaussian, and an increase in the value of dipole moment is observed for the complex of testosterone/progesterone with the ILs in comparison of individual one. The optimization energy and other thermodynamic energies of the ILs (IL1-IL3), testosterone (T), testosterone-IL (T-IL1 to T-IL3), progesterone (P), and progesterone-ILs (P-IL1 to P-IL3) are found to be negative. Further, the change in free energy for the formation of complexes at room temperature is calculated. Further, the authors have investigated the synergistic effect of testosterone and progesterone against the main protease of new coronavirus using molecular docking. It is observed that the testosterone-IL1 {IL1-3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium 2,4,6-trinitrophenolate} is found to be prominent against the main protease of SARS-CoV-2.Entities:
Keywords: DFT calculations; ionic liquids; molecular docking; progesterone; testosterone
Year: 2021 PMID: 34511718 PMCID: PMC8420490 DOI: 10.1002/poc.4273
Source DB: PubMed Journal: J Phys Org Chem ISSN: 0894-3230 Impact factor: 2.155
FIGURE 1Structures of the designed ionic liquids (IL1‐IL3), testosterone (T), progesterone (P), and the complexes (T‐IL1, T‐IL2, T‐IL3, P‐IL1, P‐IL2, P‐IL3)
FIGURE 2Representation of the frontier molecules orbitals (highest occupied molecular orbital [HOMO], lowest unoccupied molecular orbital [LUMO], and optimized geometry) of the T‐IL1 as in Figure 1
Various thermodynamics parameters (zero‐point energy, thermal energy, thermal enthalpy, and thermal free energy) along with optimization energy and dipole moment of the ionic liquids (IL1‐IL3), testosterone (T), testosterone‐IL (T‐IL1 to T‐IL3), progesterone (P), progesterone‐ILs (P‐IL1 to P‐IL3)
| System | Sum of electronic and zero‐point energies (Hartree/particles) | Sum of electronic and thermal energies (Hartree/particles) | Sum of electronic and thermal enthalpies (Hartree/particles) | Sum of electronic and thermal free energies (Hartree/particles) | Optimization energy (Hartree/particles) | Dipole moment (Debye) |
|---|---|---|---|---|---|---|
| IL1 | −1340.42 | −1340.40 | −1340.40 | −1340.48 | −1340.70 | 15.5 |
| IL2 | −931.30 | −931.29 | −931.28 | −931.35 | −931.57 | 17.6 |
| IL3 | −931.32 | −931.30 | −931.30 | −931.37 | −931.59 | 9.6 |
| T | −968.53 | −968.51 | −968.51 | −968.58 | −969.01 | 2.3 |
| T‐IL1 | −2308.97 | −2308.93 | −2308.93 | −2309.06 | −2309.72 | 16.02 |
| T‐IL2 | −1899.85 | −1899.81 | −1899.81 | −1899.93 | −1900.59 | 21.08 |
| T‐IL3 | −1899.88 | −1899.84 | −1899.84 | −1899.97 | −1900.62 | 16.15 |
| P | −891.12 | −891.101 | −891.10 | −891.17 | −891.56 | 4.49 |
| P‐IL1 | −2308.97 | −2308.93 | −2308.93 | −2309.06 | −2232.26 | 12.2 |
| P‐IL2 | −1822.45 | −1822.41 | −1822.41 | −1822.52 | −1823.16 | 16.4 |
| P‐IL3 | −1822.44 | −1822.40 | −1822.40 | −1822.52 | −1823.15 | 11.7 |
Change in formation for the formation of complexes between testosterone (T)/progesterone with the ionic liquids (IL1‐IL3)
| Change in energy for the formation of complex for testosterone | Change in free energy for the formation of complex for progesterone | ||||
|---|---|---|---|---|---|
| Complex | Hartree per particle | Kcal/Mol | Complex | Hartree per particle | Kcal/Mol |
| T‐IL1 | 0.00 | 0.00 | P‐IL1 | −77.41 | −48,574.80 |
| T‐IL2 | 0.00 | 0.00 | P‐IL2 | 0.00 | 0.00 |
| T‐IL3 | −0.02 | −12.55 | P‐IL3 | 931.37 | 584,434.70 |
Physiochemical descriptors of the ionic liquids (IL1‐IL3), testosterone (T), testosterone‐IL (T‐IL1 to T‐IL3), progesterone (P), and progesterone‐ILs (P‐IL1 to P‐IL3)
| C. No. | EL | EH | EH − L | EL + H | ɳ | Χ | S | μ | Ω |
|---|---|---|---|---|---|---|---|---|---|
| IL1 | −0.0949 | −0.2259 | −0.131 | −0.3208 | −0.0655 | 0.1604 | −7.63359 | −0.1604 | −0.1964 |
| IL2 | −0.0562 | −0.1747 | −0.1185 | −0.2309 | −0.05925 | 0.11545 | −8.43882 | −0.11545 | −0.11248 |
| IL3 | −0.056 | −0.1863 | −0.1303 | −0.2423 | −0.06515 | 0.12115 | −7.6746 | −0.12115 | −0.11264 |
| T | −0.0528 | −0.2399 | −0.1871 | −0.2927 | −0.09355 | 0.14635 | −5.34474 | −0.14635 | −0.11448 |
| T‐IL1 | −0.104 | −0.2362 | −0.1322 | −0.3402 | −0.0661 | 0.1701 | −7.5643 | −0.1701 | −0.21887 |
| T‐IL2 | −0.664 | −0.1843 | 0.4797 | −0.8483 | 0.23985 | 0.42415 | 2.084636 | −0.42415 | 0.375033 |
| T‐IL3 | −0.0718 | −0.1967 | −0.1249 | −0.2685 | −0.06245 | 0.13425 | −8.00641 | −0.13425 | −0.1443 |
| P | −0.0514 | −0.2384 | −0.187 | −0.2898 | −0.0935 | 0.1449 | −5.34759 | −0.1449 | −0.11228 |
| P‐IL1 | −0.0954 | −0.2291 | −0.1337 | −0.3245 | −0.06685 | 0.16225 | −7.47943 | −0.16225 | −0.1969 |
| P‐IL2 | −0.6158 | −0.1757 | 0.4401 | −0.7915 | 0.22005 | 0.39575 | 2.272211 | −0.39575 | 0.355869 |
| P‐IL3 | −0.0585 | −0.1744 | −0.1159 | −0.2329 | −0.05795 | 0.11645 | −8.62813 | −0.11645 | −0.117 |
Binding energy of the ionic liquids (IL1‐IL3), testosterone (T), testosterone‐IL (T‐IL1 to T‐IL3), progesterone (P), and progesterone‐ILs (P‐IL1 to P‐IL3)
| S. No. | Compound/complex | EBinding (kcal/Mol) | EVDW (kcal/Mol) | EHBond (kcal/Mol) | EElec (kcal/Mol) |
|---|---|---|---|---|---|
| 1 | IL1 | −114.16 | −66.3253 | −46.6226 | −1.2117 |
| 2 | IL2 | −85.9528 | −64.7713 | −22.2463 | 1.06481 |
| 3 | IL3 | −96.0611 | −63.9828 | −32.9083 | 0.82998 |
| 4 | Progesterone‐IL1 | −128.735 | −92.7558 | −34.6945 | −1.28521 |
| 5 | Progesterone‐IL2 | −111.432 | −88.7699 | −23.949 | 1.28673 |
| 6 | Progesterone‐IL3 | −100.153 | −79.5075 | −20.6454 | 0 |
| 7 | Progesterone | −84.3078 | −83.2889 | −1.01888 | 0 |
| 8 | Testosterone‐IL1 | −134.491 | −100.973 | −35.8091 | 2.29099 |
| 9 | Testosterone‐IL2 | −115.37 | −87.7726 | −26.0825 | −1.51536 |
| 10 | Testosterone‐IL3 | −106.117 | −94.4118 | −12.2167 | 0.512005 |
| 11 | Testosterone | −79.4062 | −73.4062 | −6 | 0 |
FIGURE 3Docked view of testosterone‐IL1 with Mpro of nCoV
FIGURE 4Interaction of T‐IL1 with the amino‐acids of Mpro of nCoV in terms of contributed energy